Alltracel’s Nanopeutics subsidiary signs new Professional Wound Care technology development agreement with ConvaTec
Alltracel Pharmaceuticals Plc., ("Alltracel" or “the Company”), (AIM:AP.L), the healthcare innovation group focused on oral care, wound care... read on
Nanopeutics signs exclusive technology agreement with HemCon Medical Technologies, Inc. for Military market
-- development of a range of specialist chitosan based nanofibre wound care technologies and products --Thursday, 18t... read on
Nanopeutics™ s.r.o agrees exclusive nanotechnology development partnership with a global leader in professional woundcare.
